12mth target range 63-91p10 Jan 2016 11:54
Adding the Croma and Access figures for their last reported year, turnover stands at around £18.2m and operating profit £690k. Turnover at CSSG has increased 19% last 2 years and 7% last year. The communications coming out of the company suggest new orders, biometric / FASTVEIN interest, international expansion, acquisition savings, increased profits, turnover growth.
Taking growth into account at the same rate turnover going forward near term will be very close to £20m and quite possibly operating profit around £1m.
SP wise, as we currently stand with last reported combined figures £18.2/690k, and taking into account potential for growth 9c.£20/£1m, I am personally targeting the sp over the next 12 months to be on a p/e of 15 between 63p-91p.
Obviously room to adapt should fastvein biometrics gain more traction.